BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
|
The Current P/B Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION is 1.22.
Share Price | ₹24.9 | Feb 07,2025 |
Market Cap | ₹107.7 Cr | |
Book Value | ₹88.2 Cr | Mar2023 - Standalone Results |
Price/Book | 1.22x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹107.7 Cr] as on Feb 07,2025
(/) Book Value [ ₹88.2 Cr] based on Mar2023 - Standalone Results
(=) P/B Ratio [ 1.22x ]
Thus, for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION , the investors are currently willing to pay '1.22 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION !
The chart below summarizes the trend in P/B Ratio of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION over the last five years.
Historical PB (Price/Book ) ratio chart of BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
PB Ratio Performance Analysis for BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio for fiscal years ending Mar2023 to Mar2019 averaged 12.48x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's operated at median p/b ratio of 1.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio peaked in Mar2021 at 83.21x.
- BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's p/b ratio hit its five-year low in Mar2022 of -18.98x.
How does BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION | 88.21 | 1.22 | 107.7 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.59 | 419,764.0 |
CIPLA LTD | 26,619.90 | 4.47 | 118,905.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.68 | 103,523.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.04 | 100,015.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 12.01 | 163,010.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.12 | 103,904.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 16.09 | 110,313.0 |
LUPIN LTD | 14,175.80 | 7.08 | 100,405.0 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.32 | 69,214.1 |
ABBOTT INDIA LTD | 3,658.73 | 17.31 | 63,315.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs BHARAT IMMUNOLOGICALS & BIOLOGICALS CORPORATION 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 1.22x |
Max industry PB | 17.31x |
Median industry PB | 6.59x |
Average industry PB | 7.90x |
You may also like the below Video Courses